IMA Advisory Services’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
ACA
SCM
IMA Advisory Services's KRYS Position: Q2 2026 in Review
IMA Advisory Services increased its Krystal Biotech (KRYS) stake by 50% in Q2 2026, buying an estimated $1.49K and bringing the position to 15 shares worth $5.58K. The position accounts for ﹤0.01% of the portfolio, ranked #889.
IMA Advisory Services first reported a position in KRYS in Q1 2026 and has held it in 2 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.
- IMA Advisory Services held 15 shares of Krystal Biotech worth $5.58K as of Q2 2026.
- IMA Advisory Services bought 5 Krystal Biotech shares in Q2 2026, an estimated $1.49K.
- Krystal Biotech made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #889 holding.
- IMA Advisory Services first reported a position in Krystal Biotech in Q1 2026 and has held it in 2 quarters since.
- 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.
Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.